Approval · Notice of Compliance 15094 · 2013
CYCLOCORT: Notice of Compliance 15094
Issued December 20, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15094
- Date
- December 20, 2013
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to product labels, product monograph and certified product information document (cpid) based on the current manufacturing practice for cyclocort cream, lotion and ointment
- Therapeutic class
- Topical corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYCLOCORT | Not yet assigned | — |
Medicinal ingredients
- AMCINONIDE 0.1 PER